Navigation Links
BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
Date:9/8/2009

an 300 per 100,000. There are approximately 66,000 deaths annually attributed to TBI in Europe.

The leading cause of TBI in the world is road traffic accidents, accounting for 40-50 percent of the hospitalizations for TBI.

There are currently no approved medications to improve outcomes following TBI.

The SyNAPSe study will build on promising results achieved in several previous clinical trials that demonstrated a mortality benefit and improved functional outcomes in TBI patients treated with progesterone. BHR has exclusively licensed the rights to a patent family claiming the use of progesterone to treat traumatic brain injury, along with preclinical and clinical data from a Phase 2 TBI study.

About BHR

Founded in January 2008, BHR Pharma, LLC (www.bhr-pharma.com) is a pharmaceutical research and development (R&D) company located near Washington, DC. BHR is committed to bringing to market specialty treatments that employ non-oral delivery systems, with an emphasis on unmet and underserved medical needs.

A wholly owned subsidiary of Besins Healthcare SA (www.besins-healthcare.com), which markets healthcare products in 93 countries, BHR manages all of Besins' global R&D activities. Those activities primarily leverage proprietary parenteral drug formulations, including the Enhanced Hydroalcoholic Gel (EHG((R))) technology pioneered and commercially launched by Besins in 1975.


'/>"/>
SOURCE BHR Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
5. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
6. Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
7. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
10. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
11. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)...  Semler Scientific, Inc. (Nasdaq: SMLR ), a ... insurers and physician groups, today reported financial results for ... "In the second quarter of 2015, Semler reported ... 54%, quarter over quarter revenue growth of 8%, and ... FloChec® units of 18%," said Doug Murphy-Chutorian, M.D., chief ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
(Date:7/30/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... the t:slim® and t:flex™ Insulin Pumps, today announced ... with Dexcom, Inc. to allow the integration of ... G5 and G6 continuous glucose monitoring ("CGM") systems. ... with Dexcom,s future CGM systems is an important ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... FDA Regarding Possible Phase III Trial Based on Human Data ... ... Neupogen(R), RICHMOND, Va., July 10, 2008 Insmed Inc.,(Nasdaq: ... medical needs, today announced that it has demonstrated the,bioequivalence of INS-19, ...
... Sosei Group Corporation,("Sosei"; TSE Mothers Index: 4565), ... Japanese Phase III clinical trial for the,emergency contraceptive ... rights to the product in Japan from HRA ... evaluate the safety and prevented,pregnancy rate of SOH-075 ...
Cached Medicine Technology:Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 2Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 3Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 4Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company 5Sosei Announces Completion of Phase III Trial for NorLevo(R) 2
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists ... associate podiatrist, creating the largest medical practice in the Mid-Atlantic region – and the ... operates 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. ...
(Date:8/2/2015)... ... August 03, 2015 , ... ... attending and exhibiting at the Association for Healthcare Documentation Integrity’s (AHDI) conference being ... are pleased for the opportunity the AHDI conference provides us to interact with ...
(Date:8/1/2015)... ... 02, 2015 , ... AlignLife Office Coordinator Heather Pugh earned the ... for patients at this natural health care center in Winamac. , "Oftentimes patients are ... "Heather's role is vital to our approach because we want to focus on the ...
(Date:8/1/2015)... ... August 01, 2015 , ... Calvary Hospital today announced that it ... Bronx campus. The goal is to bring this Torah – dating from 1880 – ... rituals and religious services. , Scroll No. 515, from the town of Taus-Domazlice, ...
(Date:8/1/2015)... ... August 01, 2015 , ... Lume Wellness creators Alex, Robert, and Sam have ... the Apple AppStore. , The app is designed to track various metrics of ... tool to view personal health and use this information for positive behavior modification. Lume ...
Breaking Medicine News(10 mins):Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2
... Three-day Symposium Focuses on Improving Drought Tolerance, ... around the world convened here today for a ... in plants. Hosted by DuPont,(NYSE: DD ) ... to share,research information among public and private organizations ...
... Eight Consecutive ... Quarters, According to MD Buyline, NASHUA, N.H., Feb. 4 ... (CAD),solutions for the early identification of cancer, today announced that ... to,the independent healthcare research group MD Buyline., In its ...
... Feb. 4 The Providence Service,Corporation (Nasdaq: ... Chief Executive Officer, is scheduled to present an ... Healthcare Services Conference on,Monday, February 11, 2008 at ... Providence,s presentation is scheduled for 12:00 p.m. EST. ...
... pain scores by more than 78% , , MONDAY, Feb. 4 ... medicine go down, a new study shows it may also ... that a simple sugar-and-water solution will also ease parents, fears ... will encourage parents to get their children vaccinated," said study ...
... New Proprietary Technology to Create Healthier and ... Higher Value ... world leader in stabilized rice bran (SRB), nutrient research and,technology, announced ... rice bran oil processing facility in South America,located in Brazil. This ...
... JUAN, Puerto Rico, Feb. 4 Triple-S,Management Corporation (NYSE: ... and Chief Executive Officer, and Juan-Jose Roman,Finance Vice President ... analysts at the UBS Global Healthcare Conference in,New York ... time. The,presentation will be broadcast live through the Internet ...
Cached Medicine News:Health News:DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 3Health News:Providence Service Corporation to Present at the 2008 UBS Global Healthcare Services Conference on February 11 2Health News:Sugar Water Eases Pain of Infant Vaccinations 2Health News:Sugar Water Eases Pain of Infant Vaccinations 3Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 2Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 3Health News:NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: